BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 6157089)

  • 1. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.
    Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ
    N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
    Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
    Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF beta 2-microglobulin in diagnosis of CNS leukemia or lymphoma.
    N Engl J Med; 1981 Feb; 304(6):362. PubMed ID: 6160401
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
    Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
    No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid beta 2-microglobulin in AIDS related central nervous system involvement.
    Lazzarin A; Castagna A; Cavalli G; Amprimo MC; Vaj M; Parravicini CL; Costanzi G; Ronchi P; Foppa CU; Moroni M; Turconi R
    J Clin Lab Immunol; 1992; 38(4):175-86. PubMed ID: 11270518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
    Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
    Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of cerebrospinal fluid beta 2-microglobulin determination in central nervous system leukemia].
    Zhang HZ; Ye X; Sun ZG
    Zhonghua Nei Ke Za Zhi; 1989 May; 28(5):262-4, 313. PubMed ID: 2680338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Central nervous system involvement of leukemia and systemic lymphoma in children: CT and MR findings].
    Tomura N; Hirano H; Kato K; Sashi R; Hashimoto M; Watarai J; Watanabe A
    No To Shinkei; 1997 Nov; 49(11):993-1000. PubMed ID: 9396030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
    Lossos IS; Breuer R; Intrator O; Lossos A
    Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta 2-microglobulin levels in cerebrospinal fluid of children with leukemia and lymphoma.
    Pudek MR; Chan KW; Rogers PC; Teasdale JM
    Clin Biochem; 1985 Jun; 18(3):180-3. PubMed ID: 3888445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulin.
    Koch TR; Lichtenfeld KM; Wiernik PH
    Cancer; 1983 Jul; 52(1):101-4. PubMed ID: 6189578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between cerebrospinal fluid osteopontin level and central nervous system involvement in childhood acute leukemia.
    Incesoy-Özdemir S; Sahin G; Bozkurt C; Oren AC; Balkaya E; Ertem U
    Turk J Pediatr; 2013; 55(1):42-9. PubMed ID: 23692831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid B2-microglobulin levels in meningeal involvement by malignancy.
    Jeffery GM; Frampton CM; Legge HM; Hart DN
    Pathology; 1990 Jan; 22(1):20-3. PubMed ID: 2194155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [beta2-Microglobulin determination's estimation in cerebrospinal fluid (author's transl)].
    Lavocat C; Merienne L; Ziegler M; Fauchier P; Riche F; Askienazy S
    Pathol Biol (Paris); 1978 Sep; 26(6):387-9. PubMed ID: 83593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].
    Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J
    Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
    Eclache V; Vu T; Le Roux G
    Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The behaviour of beta-2-microglobulin in acute and chronic leukaemias.
    Schena FP; Liso V; Losuriello V; Mera S; Bonomo L
    Biomedicine; 1980 Feb; 33(1):12-5. PubMed ID: 6154490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta 2 microglobulin in some hematologic neoplasms].
    Rodríguez MA; Lira P; Foradori A; Grebe G
    Rev Med Chil; 1989 Jun; 116(6):538-42. PubMed ID: 2664940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CXCL13 and CXCL12 in central nervous system lymphoma patients.
    Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
    Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Beta 2 microglobulin].
    Clément F
    Schweiz Med Wochenschr; 1983 Jun; 113(23):838-43. PubMed ID: 6192496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.